
DocGo (DCGO) Stock Forecast & Price Target
DocGo (DCGO) Analyst Ratings
Bulls say
DocGo Inc. reported an EBITDA of $830,000 with a 20% margin, indicating substantial profitability improvements as the company benefits from economies of scale. Patient volume growth was robust across various services, including an 11% increase in medical transportation trips and a remarkable 113% surge in home visits year-over-year, which contributed to an optimistic revision of revenue and adjusted EBITDA guidance for 2026. Additionally, with improvements in operational efficiency and strong demand management in the core transportation business, the company anticipates further enhancements in gross profit margins and continued revenue growth driven by strategic initiatives in both its Mobile Health Services and Transportation Services segments.
Bears say
DocGo Inc. has reported a concerning decline in mobile revenue for the fourth quarter of 2025, with a drop of 3% year-over-year and 8% quarter-over-quarter when excluding acquisitions and specific immigration work. The company faces challenges in achieving its adjusted EBITDA guidance, as non-GAAP operating expenses would need to decrease significantly to align with projected revenue growth, which has been hindered by a decline in organic non-migrant Mobile Health revenue despite a reported 47% growth that includes contributions from new acquisitions. Furthermore, ongoing elevated costs related to migrant revenue, along with difficulties in scaling the business, suggest lingering operational issues and a challenging revenue outlook for the core Mobile Health services segment.
This aggregate rating is based on analysts' research of DocGo and is not a guaranteed prediction by Public.com or investment advice.
DocGo (DCGO) Analyst Forecast & Price Prediction
Start investing in DocGo (DCGO)
Order type
Buy in
Order amount
Est. shares
0 shares